HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
114477.0,252858,2194-03-07 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: stridor, resp distress
   24 Hour Events:
 EKG - At [**2194-3-6**] 06:00 PM
 PAN CULTURE - At [**2194-3-6**] 06:00 PM
 INVASIVE VENTILATION - START [**2194-3-6**] 06:00 PM
 PICC LINE - START [**2194-3-6**] 06:27 PM
 ARTERIAL LINE - START [**2194-3-6**] 10:30 PM
 FEVER - 103.8
F - [**2194-3-6**] 06:39 PM
   Overnight, pt sedated on propofol but weaned to [**5-20**] successfully. Does
   not have a cuff leak this am
   Patient unable to provide history: Sedated
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Vancomycin - [**2194-3-6**] 06:00 PM
   Cefipime - [**2194-3-7**] 04:03 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Meperidine (Demerol) - [**2194-3-6**] 06:00 PM
   Pantoprazole (Protonix) - [**2194-3-6**] 08:00 PM
   Other medications:
   Changes to medical and family history: none
   Review of systems is unchanged from admission except as noted below
   Review of systems: unable to obtain [**2-17**] sedation, intubation
   Flowsheet Data as of  [**2194-3-7**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.9
C (103.8
   Tcurrent: 36.2
C (97.1
   HR: 50 (50 - 164) bpm
   BP: 151/72(102) {137/70(99) - 157/78(110)} mmHg
   RR: 7 (6 - 31) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 60 Inch
           Total In:
                                                                  1,695 mL
                                                                    638 mL
   PO:
           TF:
   IVF:
                                                                  1,513 mL
                                                                    400 mL
   Blood products:
                                                                     42 mL
                                                                    238 mL
   Total out:
                                                                  1,225 mL
                                                                  2,150 mL
   Urine:
                                                                    675 mL
                                                                  2,150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    470 mL
                                                                 -1,512 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 400 (400 - 400) mL
   Vt (Spontaneous): 530 (500 - 530) mL
   PS : 5 cmH2O
   RR (Set): 18
   RR (Spontaneous): 2
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 21
   PIP: 18 cmH2O
   SpO2: 100%
   ABG: 7.43/35/190/22/0
   Ve: 5 L/min
   PaO2 / FiO2: 475
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: 2+, No(t) Cyanosis
   Skin:  Warm, No(t) Rash:
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Normal
   Labs / Radiology
   104 K/uL
   9.6 g/dL
   206 mg/dL
   0.5 mg/dL
   22 mEq/L
   3.7 mEq/L
   13 mg/dL
   109 mEq/L
   140 mEq/L
   27.2 %
   0.4 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
   WBC
   0.7
   0.4
   Hct
   25.6
   23.8
   27.2
   Plt
   108
   104
   Cr
   0.6
   0.5
   TCO2
   24
   24
   Glucose
   203
   206
   Other labs: PT / PTT / INR:14.5/31.3/1.3, CK / CKMB / Troponin-T:475//,
   ALT / AST:61/66, Alk Phos / T Bili:148/1.1, Lactic Acid:1.8 mmol/L,
   Albumin:3.0 g/dL, LDH:1123 IU/L, Ca++:8.2 mg/dL, Mg++:2.3 mg/dL,
   PO4:3.2 mg/dL
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 2**])
 ANEMIA, OTHER
   Assessment and Plan:
   78 yo Chinese male with new diagnosis [**Hospital 4230**] transferred to [**Hospital Unit Name 10**] in acute
   respiratory distress soon after cytarabine and idarubicin
   administration.
   .
   #Respiratory Distress: Patient with tachypnea, stridor, and accessory
   muscle use roughly one hour after cytarabine and idarubicin
   administration.  He was suspected to have an anaphylactic reaction and
   was given solumedrol 125mg IV X1, benadryl 25mg IV X1, epinephrine .3mg
   IM X1, and inhaled racemic epinephrine without response.  Anesthesia
   did not report airway swelling or edema during intubation, making
   anaphylaxis less likely. [**Month (only) 11**] also be from transfusion reaction, as it
   was reported that his temperature increased during transfusion today.
   Will continue with IV steroids and get chest CTA to tule out PE, given
   left lower extremity swelling.
   -Intubation
   -IV decadron
   -chest CTA
   .
   #Tachycardia: HR 160's on presentation.  [**Month (only) 11**] be secondary to fever,
   respiratory distress, and IM epinephrine.  EKG appears to be sinus
   tachycardia.  Will avoid beta blockers in setting of epinephrine
   administration.  Will bolus with fluid and consider diltiazem. Will
   also use propofol and fentanyl for sedation.
   -Fluid Bolus
   -Dilt prn
   -avoid BB
   .
   #Fever:103.2 on presentation. Patient is neutropenic.  On cefepime for
   UTI. [**Month (only) 11**] be from chemotherapy vs. infection vs. AML.  Will cover with
   Vancomycin, given PICC placement.
   -Continue cefepime
   -Add vancomycin
   -blood, sputum, urine cx.
   .
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation. We are unsure if the echymoses is new, or
   is a result of this hematoma 1 week ago, however, the patient did have
   a 6 point hematocrit drop overnight.  he has also received 5 units of
   prbcs since [**3-1**]. The left leg is also more swollen than the right,
   raising concern for DVT.
   -Will get pelvis and left leg CT, looking for hematoma.
   -if no PE detected on chest CTA, will get ultrasound of left leg.
   -check coags
   .
   #AML - Had first dose of cytarabine and idarubicin today.  Will not be
   able to continue given anaphylaxis. Future therapy will be per oncology
   team.
   .
   #. Anemia - Combination of AML and gluteal hematoma.  will check lysis
   labs and coags. transfuse if actively bleeding.
   .
   #.Transaminitis: Possibly form reactivation of Hep B, as is HepB core
   IgM positive.  Will touch base with Hepatology in AM, continue
   lamivudine.
   -lamivudine.
   -hepatology
   .
   #. T2DM - Insulin sliding scale
   .
   . FEN - NPO
   . PPX: Bowel regimen, protonix,  Pneumoboots
   . Dispo - ICU
   ICU Care
   Nutrition: NPO for now
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","Based on the information provided in the progress note, the patient is a 78-year-old Chinese male with a new diagnosis of acute respiratory failure, anemia, and other medical conditions. The patient presented to the hospital with symptoms of tachypnea, stridor, and accessory muscle use shortly after receiving cytarabine and idarubicin administration. He was suspected to have an anaphylactic reaction but did not respond to treatment with solute, benadryl, epinephrine, and inhaled racemic epinephrine.

The patient's respiratory distress was initially attributed to anaphylaxis or a transfusion reaction, but anesthesia did not report any airway swelling or edema during intubation, making anaphylaxis less likely. The patient's temperature increased during transfusion, raising the possibility of a transfusion reaction. The plan is to continue with IV steroids and perform a chest CTA to rule out pulmonary embolism (PE), given the left lower extremity swelling.

The patient's tachycardia is likely secondary to fever, respiratory distress, and IM epinephrine. An EKG shows sinus tachycardia. Beta blockers should be avoided in the setting of epinephrine administration. Fluid bolus, diltiazem, propofol, and fentanyl will be used for sedation.

The patient has a fever of 103.2, which may be due to chemotherapy, infection,"
114477.0,252858,2194-03-07 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: stridor, resp distress
   24 Hour Events:
 EKG - At [**2194-3-6**] 06:00 PM
 PAN CULTURE - At [**2194-3-6**] 06:00 PM
 INVASIVE VENTILATION - START [**2194-3-6**] 06:00 PM
 PICC LINE - START [**2194-3-6**] 06:27 PM
 ARTERIAL LINE - START [**2194-3-6**] 10:30 PM
 FEVER - 103.8
F - [**2194-3-6**] 06:39 PM
   Overnight, pt sedated on propofol but weaned to [**5-20**] successfully. Does
   not have a cuff leak this am
   Patient unable to provide history: Sedated
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Vancomycin - [**2194-3-6**] 06:00 PM
   Cefipime - [**2194-3-7**] 04:03 AM
   Infusions:
   Propofol - 30 mcg/Kg/min
   Other ICU medications:
   Meperidine (Demerol) - [**2194-3-6**] 06:00 PM
   Pantoprazole (Protonix) - [**2194-3-6**] 08:00 PM
   Other medications:
   Changes to medical and family history: none
   Review of systems is unchanged from admission except as noted below
   Review of systems: unable to obtain [**2-17**] sedation, intubation
   Flowsheet Data as of  [**2194-3-7**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.9
C (103.8
   Tcurrent: 36.2
C (97.1
   HR: 50 (50 - 164) bpm
   BP: 151/72(102) {137/70(99) - 157/78(110)} mmHg
   RR: 7 (6 - 31) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 60 Inch
           Total In:
                                                                  1,695 mL
                                                                    638 mL
   PO:
           TF:
   IVF:
                                                                  1,513 mL
                                                                    400 mL
   Blood products:
                                                                     42 mL
                                                                    238 mL
   Total out:
                                                                  1,225 mL
                                                                  2,150 mL
   Urine:
                                                                    675 mL
                                                                  2,150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    470 mL
                                                                 -1,512 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 400 (400 - 400) mL
   Vt (Spontaneous): 530 (500 - 530) mL
   PS : 5 cmH2O
   RR (Set): 18
   RR (Spontaneous): 2
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 21
   PIP: 18 cmH2O
   SpO2: 100%
   ABG: 7.43/35/190/22/0
   Ve: 5 L/min
   PaO2 / FiO2: 475
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: 2+, No(t) Cyanosis
   Skin:  Warm, No(t) Rash:
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Normal
   Labs / Radiology
   104 K/uL
   9.6 g/dL
   206 mg/dL
   0.5 mg/dL
   22 mEq/L
   3.7 mEq/L
   13 mg/dL
   109 mEq/L
   140 mEq/L
   27.2 %
   0.4 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
   WBC
   0.7
   0.4
   Hct
   25.6
   23.8
   27.2
   Plt
   108
   104
   Cr
   0.6
   0.5
   TCO2
   24
   24
   Glucose
   203
   206
   Other labs: PT / PTT / INR:14.5/31.3/1.3, CK / CKMB / Troponin-T:475//,
   ALT / AST:61/66, Alk Phos / T Bili:148/1.1, Lactic Acid:1.8 mmol/L,
   Albumin:3.0 g/dL, LDH:1123 IU/L, Ca++:8.2 mg/dL, Mg++:2.3 mg/dL,
   PO4:3.2 mg/dL
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 2**])
 ANEMIA, OTHER
   Assessment and Plan:
   78 yo Chinese male with new diagnosis [**Hospital 4230**] transferred to [**Hospital Unit Name 10**] in acute
   respiratory distress soon after cytarabine and idarubicin
   administration.
   .
   #Respiratory Distress: Patient with tachypnea, stridor, and accessory
   muscle use roughly one hour after cytarabine and idarubicin
   administration.  He was suspected to have an anaphylactic reaction and
   was given solumedrol 125mg IV X1, benadryl 25mg IV X1, epinephrine .3mg
   IM X1, and inhaled racemic epinephrine without response.  Anesthesia
   did not report airway swelling or edema during intubation, making
   anaphylaxis less likely. Was thought to possibly be from transfusion
   reaction, as it was reported that his temperature increased during
   transfusion- however per blood bank, there was no transfusion rxn.  CTA
   overnight ruled out PE although there were 2 v small recanulated PE
   and a pulm nodule. Doing well on [**5-20**] this am with a cuff leak.
   -extubated today
   -monitor post extubation ABG
   .
   #Tachycardia: HR 160's on presentation.  Likely secondary to
   combination of fever, respiratory distress, and IM epinephrine.  EKG
   sinus tachycardia.  Has resolved. Will monitor
   .
   #Fever:103.2 on presentation. Patient is neutropenic.  On cefepime for
   UTI. [**Month (only) 11**] be from chemotherapy vs. infection vs. AML.  Will cover with
   Vancomycin, given PICC placement.
   -Continue cefepime, vanco
   -blood, sputum, urine cx.
   .
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation. .Had a 6 point hematocrit drop 2/18. CT
   pelvis showed no acute change in size of hematoma on prelim read
   -f/u final CT pelvis read
   -LENI
s today given swelling of left leg
   -trend Hct, plt, CK.
   -
   #AML - Had first dose of cytarabine and idarubicin [**3-6**].  Will not be
   able to continue given anaphylaxis. Future therapy will be per oncology
   team.
   -f/u heme onc recs
   .
   #. Anemia - Combination of AML and gluteal hematoma.
   -transfuse for Hct <25, plt<50
   .
   #.Transaminitis: Possibly form reactivation of Hep B, as is HepB core
   IgM positive.
   - continue lamivudine.
   -f/u with hepatology
   .
   #. T2DM - Insulin sliding scale
   .
   . FEN
 NPO for now
   . PPX: Bowel regimen, protonix,  Pneumoboots
   . Dispo - ICU
   ICU Care
   Nutrition: NPO for now
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","Summary of Progress Note:

The patient is a 78-year-old male with a new diagnosis of acute respiratory failure, anemia, and other complications. He was transferred to the ICU in acute respiratory distress shortly after receiving cytarabine and idarubicin. The patient had tachypnea, stridor, and accessory muscle use, which raised suspicion for anaphylaxis. However, anesthesia did not report any airway swelling or edema during intubation, making anaphylaxis less likely.

The patient's temperature increased during transfusion, but the blood bank reported no transfusion reaction. A CT angiography overnight ruled out pulmonary embolism (PE), although there were two small recanalized PEs and a pulmonary nodule. The patient is currently doing well on [5-20] with a cuff leak and is expected to be extubated today. Post-extubation ABG will be monitored.

The patient had a heart rate of 160's on presentation, likely secondary to fever, respiratory distress, and IM epinephrine. The EKG showed sinus tachycardia, which has since resolved. The patient's fever is 103.2, and he is neutropenic. Cefepime has been initiated for a possible urinary tract infection (UTI). Additionally, vancomycin has been started due to the PICC placement.

The patient has echymoses extending from the left buttock to just behind the knee,"
114477.0,252858,2194-03-07 10:03:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   No cuff leak.
   Vascular c/s overnight.
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Cefipime - [**2194-3-7**] 04:03 AM
   Vancomycin - [**2194-3-7**] 08:00 AM
   Infusions:
   Propofol - 40 mcg/Kg/min
   Other ICU medications:
   Meperidine (Demerol) - [**2194-3-6**] 06:00 PM
   Pantoprazole (Protonix) - [**2194-3-6**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2194-3-7**] 09:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.9
C (103.8
   Tcurrent: 34.5
C (94.1
   HR: 55 (50 - 164) bpm
   BP: 164/79(112) {137/70(99) - 168/79(112)} mmHg
   RR: 17 (6 - 31) insp/min
   SpO2: 100%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
           Total In:
                                                                  1,695 mL
                                                                    968 mL
   PO:
           TF:
   IVF:
                                                                  1,513 mL
                                                                    659 mL
   Blood products:
                                                                     42 mL
                                                                    238 mL
   Total out:
                                                                  1,225 mL
                                                                  2,670 mL
   Urine:
                                                                    675 mL
                                                                  2,670 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    470 mL
                                                                 -1,702 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 400 (400 - 400) mL
   Vt (Spontaneous): 614 (500 - 614) mL
   PS : 5 cmH2O
   RR (Set): 18
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 21
   PIP: 18 cmH2O
   SpO2: 100%
   ABG: 7.43/35/190/22/0
   Ve: 4.2 L/min
   PaO2 / FiO2: 475
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Coarse, + cuff leak: )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: No edema, Good pulses.
   Skin:  Significant ecchymoses L flank extending down extremitiy
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   9.6 g/dL
   104 K/uL
   206 mg/dL
   0.5 mg/dL
   22 mEq/L
   3.7 mEq/L
   13 mg/dL
   109 mEq/L
   140 mEq/L
   27.2 %
   0.4 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
   WBC
   0.7
   0.4
   Hct
   25.6
   23.8
   27.2
   Plt
   108
   104
   Cr
   0.6
   0.5
   TCO2
   24
   24
   Glucose
   203
   206
   Other labs: PT / PTT / INR:14.5/31.3/1.3, CK / CKMB / Troponin-T:475//,
   ALT / AST:61/66, Alk Phos / T Bili:148/1.1, Lactic Acid:1.8 mmol/L,
   Albumin:3.0 g/dL, LDH:1123 IU/L, Ca++:8.2 mg/dL, Mg++:2.3 mg/dL,
   PO4:3.2 mg/dL
   Imaging: CT - No acute PE.  Old recanulated PEs. L pleural based
   nodule. Posterior atelectasis.
   Microbiology: No new data.
   Assessment and Plan
   78 yo Cantonese-speaking male admitted last week with AML s/p first
   cycle of idarubucin/cytarabine with [**Hospital 4257**] transferred to [**Hospital Unit Name 10**] with
   acute resp distress requiring intubation and concerns for anaphylaxis
   or transfusion reaction.
   #Respiratory Distress: Patient with fever, tachypnea, tachycardia,
   stridor, and accessory muscle use roughly one hour after cytarabine and
   idarubicin administration and PRBC transfusion.  He was suspected to
   have an anaphylactic reaction (no airway swelling on intubation) or
   transfusion reaction.  Chest CTA without new PE.
   - Extubation now with cuff leak.
   - IV decadron
   - F/U final CTA read
   #Tachycardia: HR 160's on presentation.  [**Month (only) 11**] be secondary to fever,
   respiratory distress, and IM epinephrine.  EKG appears to be sinus
   tachycardia.  Now resolved.
   - Follow
   #Neutropenic fever: Unclear source. On cefepime for UTI, vanc for
   possible line sepsis.
   - Cefepime/vanc
   - F/U cultures
   - Trend counts
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation.  Vascular saw o/n
 no compartment
   syndrome.
   - F/U lenis
   - Blood products to maintain Hct of 25 / Plts of 50.
   - q8h Hct
   #AML - Had first dose of cytarabine and idarubicin yesterday. Future
   therapy will be per oncology team.
   Other issues per resident note.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Need for restraints reviewed
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 35 minutes
   Patient is critically ill
","Summary of Progress Note:
- The patient is a 78-year-old male with a history of acute myeloid leukemia (AML) who was admitted last week.
- He presented with acute respiratory distress and concerns for anaphylaxis or transfusion reaction.
- The patient was intubated and transferred to the ICU.
- On the current day, the patient's vital signs include a temperature of 39.9Â°C, heart rate of 55 bpm, blood pressure ranging from 112-168/70-112 mmHg, respiratory rate of 17 breaths per minute, and oxygen saturation of 100%.
- The patient is on mechanical ventilation with a tidal volume of 400 mL, positive end-expiratory pressure (PEEP) of 5 cmH2O, and fraction of inspired oxygen (FiO2) of 40%.
- The patient has received multiple units of blood products and has a slightly low hemoglobin level of 9.6 g/dL.
- The patient's white blood cell count is low at 0.7 K/uL, and platelet count is slightly low at 108 K/uL.
- The patient's blood glucose level is elevated at 203 mg/dL.
- Imaging shows no acute pulmonary embolism but does reveal old recanalized pulmonary emboli, a left pleural-based nodule, and posterior atelectasis.
- The patient has been diagnosed with neutropenic fever and is being treated with"
114477.0,252858,2194-03-07 10:03:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   No cuff leak.
   Vascular c/s overnight.
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Cefipime - [**2194-3-7**] 04:03 AM
   Vancomycin - [**2194-3-7**] 08:00 AM
   Infusions:
   Propofol - 40 mcg/Kg/min
   Other ICU medications:
   Meperidine (Demerol) - [**2194-3-6**] 06:00 PM
   Pantoprazole (Protonix) - [**2194-3-6**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2194-3-7**] 09:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.9
C (103.8
   Tcurrent: 34.5
C (94.1
   HR: 55 (50 - 164) bpm
   BP: 164/79(112) {137/70(99) - 168/79(112)} mmHg
   RR: 17 (6 - 31) insp/min
   SpO2: 100%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
           Total In:
                                                                  1,695 mL
                                                                    968 mL
   PO:
           TF:
   IVF:
                                                                  1,513 mL
                                                                    659 mL
   Blood products:
                                                                     42 mL
                                                                    238 mL
   Total out:
                                                                  1,225 mL
                                                                  2,670 mL
   Urine:
                                                                    675 mL
                                                                  2,670 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    470 mL
                                                                 -1,702 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 400 (400 - 400) mL
   Vt (Spontaneous): 614 (500 - 614) mL
   PS : 5 cmH2O
   RR (Set): 18
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 21
   PIP: 18 cmH2O
   SpO2: 100%
   ABG: 7.43/35/190/22/0
   Ve: 4.2 L/min
   PaO2 / FiO2: 475
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Coarse, + cuff leak: )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: No edema, Good pulses.
   Skin:  Significant ecchymoses L flank extending down extremitiy
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   9.6 g/dL
   104 K/uL
   206 mg/dL
   0.5 mg/dL
   22 mEq/L
   3.7 mEq/L
   13 mg/dL
   109 mEq/L
   140 mEq/L
   27.2 %
   0.4 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
   WBC
   0.7
   0.4
   Hct
   25.6
   23.8
   27.2
   Plt
   108
   104
   Cr
   0.6
   0.5
   TCO2
   24
   24
   Glucose
   203
   206
   Other labs: PT / PTT / INR:14.5/31.3/1.3, CK / CKMB / Troponin-T:475//,
   ALT / AST:61/66, Alk Phos / T Bili:148/1.1, Lactic Acid:1.8 mmol/L,
   Albumin:3.0 g/dL, LDH:1123 IU/L, Ca++:8.2 mg/dL, Mg++:2.3 mg/dL,
   PO4:3.2 mg/dL
   Imaging: CT - No acute PE.  Old recanulated PEs. L pleural based
   nodule. Posterior atelectasis.
   Microbiology: No new data.
   Assessment and Plan
   78 yo Cantonese-speaking male admitted last week with AML s/p first
   cycle of idarubucin/cytarabine with [**Hospital 4257**] transferred to [**Hospital Unit Name 10**] with
   acute resp distress requiring intubation and concerns for anaphylaxis
   or transfusion reaction.
   #Respiratory Distress: Patient with fever, tachypnea, tachycardia,
   stridor, and accessory muscle use roughly one hour after cytarabine and
   idarubicin administration and PRBC transfusion.  He was suspected to
   have an anaphylactic reaction (no airway swelling on intubation) or
   transfusion reaction.  Chest CTA without new PE.
   - Extubation now with cuff leak.
   - IV decadron
   - F/U final CTA read regarding old PEs
   #Tachycardia: HR 160's on presentation.  [**Month (only) 11**] be secondary to fever,
   respiratory distress, and IM epinephrine.  EKG appears to be sinus
   tachycardia.  Now resolved.
   - Follow
   #Neutropenic fever: Unclear source. On cefepime for UTI, vanc for
   possible line sepsis.
   - Cefepime/vanc
   - F/U cultures
   - Trend counts
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation.  Vascular saw o/n
 no compartment
   syndrome.
   - F/U lenis
   - Blood products to maintain Hct of 25 / Plts of 50.
   - q8h Hct
   - IVF for elevated CK
   #AML - Had first dose of cytarabine and idarubicin yesterday. Future
   therapy will be per oncology team.
   Other issues per resident note.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Need for restraints reviewed
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 35 minutes
   Patient is critically ill
","Summary of Progress Note:
The patient is a 78-year-old male with a history of acute myeloid leukemia (AML) who was admitted last week after experiencing respiratory distress following the administration of cytarabine and idarubicin. The patient required intubation and was transferred to the ICU due to concerns for anaphylaxis or transfusion reaction. 

Upon arrival in the ICU, the patient presented with fever, tachypnea, tachycardia, stridor, and accessory muscle use. Chest CTA was performed without new pulmonary embolism (PE). The patient's heart rate was in the 160s on presentation but has since resolved. 

The patient also has neutropenic fever of unclear origin, for which he is receiving cefepime and vancomycin. He has echymoses extending from his left buttock to just behind his knee, likely due to a recent bone marrow biopsy complicated by a left gluteal hematoma. 

The patient's laboratory results show anemia, thrombocytopenia, and elevated creatinine levels. Imaging reveals old recanalized PEs, a left pleural-based nodule, and posterior atelectasis. 

Plan:
The patient is currently on mechanical ventilation with CPAP/PSV mode, set with a tidal volume of 400 mL, respiratory rate of 18 breaths per minute, and positive end-expiratory pressure (PEEP) of 5 cmH"
114477.0,252858,2194-03-07 10:03:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   No cuff leak.
   Vascular c/s overnight.
   CT negative for PE
   Pelvic/ leg CT does not worsening of large hematoma despite hct drop
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Cefipime - [**2194-3-7**] 04:03 AM
   Vancomycin - [**2194-3-7**] 08:00 AM
   Infusions:
   Propofol - 40 mcg/Kg/min
   Other ICU medications:
   Meperidine (Demerol) - [**2194-3-6**] 06:00 PM
   Pantoprazole (Protonix) - [**2194-3-6**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2194-3-7**] 09:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.9
C (103.8
   Tcurrent: 34.5
C (94.1
   HR: 55 (50 - 164) bpm
   BP: 164/79(112) {137/70(99) - 168/79(112)} mmHg
   RR: 17 (6 - 31) insp/min
   SpO2: 100%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
           Total In:
                                                                  1,695 mL
                                                                    968 mL
   PO:
           TF:
   IVF:
                                                                  1,513 mL
                                                                    659 mL
   Blood products:
                                                                     42 mL
                                                                    238 mL
   Total out:
                                                                  1,225 mL
                                                                  2,670 mL
   Urine:
                                                                    675 mL
                                                                  2,670 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    470 mL
                                                                 -1,702 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 400 (400 - 400) mL
   Vt (Spontaneous): 614 (500 - 614) mL
   PS : 5 cmH2O
   RR (Set): 18
   RR (Spontaneous): 8
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 21
   PIP: 18 cmH2O
   SpO2: 100%
   ABG: 7.43/35/190/22/0
   Ve: 4.2 L/min
   PaO2 / FiO2: 475
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Coarse, + cuff leak: )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: No edema, Good pulses.
   Skin:  Significant ecchymoses L flank extending down extremitiy
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   9.6 g/dL
   104 K/uL
   206 mg/dL
   0.5 mg/dL
   22 mEq/L
   3.7 mEq/L
   13 mg/dL
   109 mEq/L
   140 mEq/L
   27.2 %
   0.4 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
   WBC
   0.7
   0.4
   Hct
   25.6
   23.8
   27.2
   Plt
   108
   104
   Cr
   0.6
   0.5
   TCO2
   24
   24
   Glucose
   203
   206
   Other labs: PT / PTT / INR:14.5/31.3/1.3, CK / CKMB / Troponin-T:475//,
   ALT / AST:61/66, Alk Phos / T Bili:148/1.1, Lactic Acid:1.8 mmol/L,
   Albumin:3.0 g/dL, LDH:1123 IU/L, Ca++:8.2 mg/dL, Mg++:2.3 mg/dL,
   PO4:3.2 mg/dL
   Imaging: CT - No acute PE.  Old recanulated PEs. L pleural based
   nodule. Posterior atelectasis.
   Microbiology: No new data.
   Assessment and Plan
   78 yo Cantonese-speaking male admitted last week with AML s/p first
   cycle of idarubucin/cytarabine with [**Hospital 4257**] transferred to [**Hospital Unit Name 10**] with
   acute resp distress requiring intubation and concerns for anaphylaxis
   or transfusion reaction.
   #Respiratory Distress: Patient with fever, tachypnea, tachycardia,
   stridor, and accessory muscle use roughly one hour after cytarabine and
   idarubicin administration and PRBC transfusion.  He was suspected to
   have an anaphylactic reaction (no airway swelling on intubation) or
   transfusion reaction.  Chest CTA without new PE.
   - Extubation now with cuff leak.
   - IV decadron today, then stop
   - F/U final CTA read regarding old PEs
   #Tachycardia: HR 160's on presentation.  [**Month (only) 11**] be secondary to fever,
   respiratory distress, and IM epinephrine.  EKG appears to be sinus
   tachycardia.  Now resolved.
   - Follow
   #Neutropenic fever: Unclear source. On cefepime for UTI, vanc for
   possible line sepsis.
   - Cefepime/vanc
   - F/U cultures
   - Trend counts
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation.  Vascular saw o/n
 no compartment
   syndrome.
   - F/U lenis
   - Blood products to maintain Hct of 25 / Plts of 50.
   - q8h Hct
   - IVF for elevated CK
   #AML - Had first dose of cytarabine and idarubicin yesterday. Future
   therapy will be per oncology team.
   Other issues per resident note.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Need for restraints reviewed
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 35 minutes
   Patient is critically ill
","Summary:
The patient is a 78-year-old male with a history of acute myeloid leukemia (AML) who was admitted last week. He presented with respiratory distress, suspected anaphylaxis or transfusion reaction, and required intubation. The patient has been diagnosed with multiple medical complications including neutropenic fever, tachycardia, echymoses, and AML. He is currently being treated with antibiotics, blood products, and chemotherapy drugs. The patient is critically ill and requires ongoing monitoring and management in the ICU.

Potential Medical Complications:
1. Respiratory Distress: The patient initially presented with respiratory distress and required intubation. There is a risk of further respiratory compromise due to underlying AML, potential infection, or complications from mechanical ventilation.
2. Neutropenic Fever: The patient has an unclear source of fever and is at risk for infections due to neutropenia. This increases the risk of sepsis and organ dysfunction.
3. Tachycardia: The patient had an elevated heart rate on presentation, which could be secondary to fever, respiratory distress, or administration of epinephrine. Tachycardia can lead to decreased cardiac output and end-organ hypoperfusion.
4. Echymoses: The patient has extensive ecchymoses extending from the left buttock to just behind the knee. These may be related to a previous bone marrow biopsy complicated by a left gluteal hematoma."
114477.0,252858,2194-03-08 07:47:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: 78 yo Chinese male with new diagnosis AML, transferred
   to [**Hospital Unit Name 10**] in acute respiratory distress soon after cytarabine and
   idarubicin administration.
   24 Hour Events:
 ULTRASOUND - At [**2194-3-7**] 08:00 AM
   bilat LE
 INVASIVE VENTILATION - STOP [**2194-3-7**] 12:55 PM
   - extubated without complications, did well afterward
   - family came in, specifically son, daughter, and wife. Children wanted
   to know exactly what his oncology plan was and were anxious about
   continuing chemo, requested to speak to attending overnight; spoke to
   fellow.  We reassured them that father would not receive chemo without
   first consulting them and that the issue could be further explored in
   morning.
   - Transfused 1u for Hct 24.5 <- 27
   - received maintenance IVF for rhabdo tx
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Vancomycin - [**2194-3-7**] 07:53 PM
   Cefipime - [**2194-3-8**] 03:47 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2194-3-7**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2194-3-8**] 07:47 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 36
C (96.8
   HR: 60 (54 - 70) bpm
   BP: 143/69(97) {131/61(87) - 164/80(112)} mmHg
   RR: 13 (8 - 24) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 61 Inch
           Total In:
                                                                  3,741 mL
                                                                  1,522 mL
   PO:
                                                                    250 mL
                                                                    100 mL
   TF:
   IVF:
                                                                  3,183 mL
                                                                  1,280 mL
   Blood products:
                                                                    238 mL
                                                                    142 mL
   Total out:
                                                                  4,130 mL
                                                                    935 mL
   Urine:
                                                                  4,130 mL
                                                                    935 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -389 mL
                                                                    587 mL
   Respiratory support
   O2 Delivery Device: None
   Ventilator mode: Standby
   Vt (Spontaneous): 450 (450 - 614) mL
   PS : 5 cmH2O
   RR (Spontaneous): 20
   PEEP: 5 cmH2O
   FiO2: 40%
   SpO2: 95%
   ABG: ///21/
   Ve: 7.8 L/min
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric)
   Extremities: Right: 1+, Left: 1+
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   8.8 g/dL
   179 mg/dL
   0.6 mg/dL
   21 mEq/L
   3.5 mEq/L
   15 mg/dL
   114 mEq/L
   143 mEq/L
   24.5 %
   0.3 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
                             [**2194-3-7**]  10:11 AM
                             [**2194-3-7**]  05:47 PM
                             [**2194-3-8**]  03:31 AM
   WBC
   0.7
   0.4
   0.3
   Hct
   25.6
   23.8
   27.2
   26.2
   26.6
   24.5
   Plt
   108
   104
   109
   105
   90
   Cr
   0.6
   0.5
   0.6
   TCO2
   24
   24
   Glucose
   [**Telephone/Fax (3) 4280**]
   Other labs: PT / PTT / INR:14.8/32.3/1.3, CK / CKMB / Troponin-T:440//,
   ALT / AST:49/49, Alk Phos / T Bili:114/0.5, Differential-Neuts:50.0 %,
   Band:0.0 %, Lymph:38.0 %, Mono:0.0 %, Eos:0.0 %, Lactic Acid:1.8
   mmol/L, Albumin:3.0 g/dL, LDH:1123 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:3.2 mg/dL
   Assessment and Plan
   78 yo Chinese male with new diagnosis [**Hospital 4230**] transferred to [**Hospital Unit Name 10**] in acute
   respiratory distress soon after cytarabine and idarubicin
   administration.
   #Respiratory Distress: Patient with tachypnea, stridor, and accessory
   muscle use roughly one hour after cytarabine and idarubicin
   administration.  He was suspected to have an anaphylactic reaction and
   was given solumedrol 125mg IV X1, benadryl 25mg IV X1, epinephrine .3mg
   IM X1, and inhaled racemic epinephrine without response.  Anesthesia
   did not report airway swelling or edema during intubation, making
   anaphylaxis less likely. Was thought to possibly be from transfusion
   reaction, as it was reported that his temperature increased during
   transfusion- however per blood bank, there was no transfusion rxn.  CTA
   overnight ruled out PE although there were 2 v small recanulated PE
   and a pulm nodule. S/p extubation on [**2194-3-7**] and is breathing
   comfortably but etiology of respiratory distress remains unclear.
   - Continue dexamethasone
   - oncology would like to treat with chemo today; will discuss treatment
   options with family, risks/benefits of continued treatment and
   different agents
   - will stay in ICU if receiving next dose of chemo today; otherwise,
   call out to floor
   #Febrile neutropenia:103.2 on presentation. Patient is neutropenic.  On
   cefepime for UTI. [**Month (only) 11**] be from chemotherapy vs. infection vs. AML.  Will
   cover with Vancomycin, given PICC placement.
   -Continue cefepime, vanco
   -f/u blood, sputum, urine cx.
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation. .Had a 6 point hematocrit drop 2/18. CT
   pelvis showed no acute change in size of hematoma on prelim read.  Hct
   stabilizing, LLE LENIs neg.
   -trend Hct, plt, CK.
   #AML - Had first dose of cytarabine and idarubicin [**3-6**].  Will not be
   able to continue given anaphylaxis. Future therapy will be per oncology
   team.
   -f/u heme onc recs
   - respiratory distress mgmnt as above
   #. Anemia - Combination of AML and gluteal hematoma.
   - transfuse for Hct <25, plt<50
   #.Transaminitis: Possibly form reactivation of Hep B, as is HepB core
   IgM positive.
   - continue lamivudine.
   -f/u with hepatology
   #. T2DM - Insulin sliding scale
   FEN
 NPO for now
   PPX: Bowel regimen, protonix,  Pneumoboots
   Dispo - ICU
   ICU Care
   Nutrition: diabetic diet
   Glycemic Control:
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Summary:
The patient is a 78-year-old Chinese male with a new diagnosis of acute myeloid leukemia (AML). He was transferred to the ICU in acute respiratory distress after receiving cytarabine and idarubicin. The patient had an allergic reaction to the chemotherapy, and despite receiving treatment for anaphylaxis, he did not show improvement. He was intubated and mechanically ventilated but was successfully extubated without complications. The patient's respiratory distress remains unclear, and further evaluation is needed. 

The patient has several other medical issues, including febrile neutropenia, echymoses, AML, anemia, transaminitis, and type 2 diabetes mellitus (T2DM). He is receiving appropriate treatments for these conditions, including antibiotics, chemotherapy, blood transfusions, and medication for his diabetes. The patient's blood work shows some abnormalities, including low white blood cell count, low hemoglobin, and elevated lactate dehydrogenase (LDH) levels. 

Potential Medical Complications:
1. Respiratory Distress: The patient's respiratory distress could be due to various causes, including anaphylaxis, transfusion reaction, or pneumonia. Further investigation is necessary to determine the exact cause and prevent future episodes.
2. Febrile Neutropenia: The patient is at risk for infections due to his low white blood cell count. Close monitoring for signs of infection and prompt treatment with antibiotics are crucial.
3"
114477.0,252858,2194-03-08 07:47:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: 78 yo Chinese male with new diagnosis AML, transferred
   to [**Hospital Unit Name 10**] in acute respiratory distress soon after cytarabine and
   idarubicin administration.
   24 Hour Events:
 ULTRASOUND - At [**2194-3-7**] 08:00 AM
   bilat LE
 INVASIVE VENTILATION - STOP [**2194-3-7**] 12:55 PM
   - extubated without complications, did well afterward
   - family came in, specifically son, daughter, and wife. Children wanted
   to know exactly what his oncology plan was and were anxious about
   continuing chemo, requested to speak to attending overnight; spoke to
   fellow.  We reassured them that father would not receive chemo without
   first consulting them and that the issue could be further explored in
   morning.
   - Transfused 1u for Hct 24.5 <- 27
   - received maintenance IVF for rhabdo tx
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Vancomycin - [**2194-3-7**] 07:53 PM
   Cefipime - [**2194-3-8**] 03:47 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2194-3-7**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2194-3-8**] 07:47 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 36
C (96.8
   HR: 60 (54 - 70) bpm
   BP: 143/69(97) {131/61(87) - 164/80(112)} mmHg
   RR: 13 (8 - 24) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 61 Inch
           Total In:
                                                                  3,741 mL
                                                                  1,522 mL
   PO:
                                                                    250 mL
                                                                    100 mL
   TF:
   IVF:
                                                                  3,183 mL
                                                                  1,280 mL
   Blood products:
                                                                    238 mL
                                                                    142 mL
   Total out:
                                                                  4,130 mL
                                                                    935 mL
   Urine:
                                                                  4,130 mL
                                                                    935 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -389 mL
                                                                    587 mL
   Respiratory support
   O2 Delivery Device: None
   Ventilator mode: Standby
   Vt (Spontaneous): 450 (450 - 614) mL
   PS : 5 cmH2O
   RR (Spontaneous): 20
   PEEP: 5 cmH2O
   FiO2: 40%
   SpO2: 95%
   ABG: ///21/
   Ve: 7.8 L/min
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric)
   Extremities: Right: 1+, Left: 1+
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   90 K/uL
   8.8 g/dL
   179 mg/dL
   0.6 mg/dL
   21 mEq/L
   3.5 mEq/L
   15 mg/dL
   114 mEq/L
   143 mEq/L
   24.5 %
   0.3 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
                             [**2194-3-7**]  10:11 AM
                             [**2194-3-7**]  05:47 PM
                             [**2194-3-8**]  03:31 AM
   WBC
   0.7
   0.4
   0.3
   Hct
   25.6
   23.8
   27.2
   26.2
   26.6
   24.5
   Plt
   108
   104
   109
   105
   90
   Cr
   0.6
   0.5
   0.6
   TCO2
   24
   24
   Glucose
   [**Telephone/Fax (3) 4280**]
   Other labs: PT / PTT / INR:14.8/32.3/1.3, CK / CKMB / Troponin-T:440//,
   ALT / AST:49/49, Alk Phos / T Bili:114/0.5, Differential-Neuts:50.0 %,
   Band:0.0 %, Lymph:38.0 %, Mono:0.0 %, Eos:0.0 %, Lactic Acid:1.8
   mmol/L, Albumin:3.0 g/dL, LDH:1123 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:3.2 mg/dL
   Assessment and Plan
   78 yo Chinese male with new diagnosis [**Hospital 4230**] transferred to [**Hospital Unit Name 10**] in acute
   respiratory distress soon after cytarabine and idarubicin
   administration.
   #Respiratory Distress: Patient with tachypnea, stridor, and accessory
   muscle use roughly one hour after cytarabine and idarubicin
   administration.  He was suspected to have an anaphylactic reaction and
   was given solumedrol 125mg IV X1, benadryl 25mg IV X1, epinephrine .3mg
   IM X1, and inhaled racemic epinephrine without response.  Anesthesia
   did not report airway swelling or edema during intubation, making
   anaphylaxis less likely. Was thought to possibly be from transfusion
   reaction, as it was reported that his temperature increased during
   transfusion- however per blood bank, there was no transfusion rxn.  CTA
   overnight ruled out PE although there were 2 v small recanulated PE
   and a pulm nodule. Doing well on [**5-20**] this am with a cuff leak.
   -extubated today
   -monitor post extubation ABG
   #Tachycardia: HR 160's on presentation.  Likely secondary to
   combination of fever, respiratory distress, and IM epinephrine.  EKG
   sinus tachycardia.  Has resolved. Will monitor
   #Fever:103.2 on presentation. Patient is neutropenic.  On cefepime for
   UTI. [**Month (only) 11**] be from chemotherapy vs. infection vs. AML.  Will cover with
   Vancomycin, given PICC placement.
   -Continue cefepime, vanco
   -blood, sputum, urine cx.
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation. .Had a 6 point hematocrit drop 2/18. CT
   pelvis showed no acute change in size of hematoma on prelim read
   -f/u final CT pelvis read
   -LENI
s today given swelling of left leg
   -trend Hct, plt, CK.
   #AML - Had first dose of cytarabine and idarubicin [**3-6**].  Will not be
   able to continue given anaphylaxis. Future therapy will be per oncology
   team.
   -f/u heme onc recs
   #. Anemia - Combination of AML and gluteal hematoma.
   - transfuse for Hct <25, plt<50
   #.Transaminitis: Possibly form reactivation of Hep B, as is HepB core
   IgM positive.
   - continue lamivudine.
   -f/u with hepatology
   #. T2DM - Insulin sliding scale
   FEN
 NPO for now
   PPX: Bowel regimen, protonix,  Pneumoboots
   Dispo - ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Summary of Progress Note:
- 78-year-old Chinese male with new diagnosis of acute myeloid leukemia (AML) transferred to ICU in acute respiratory distress after receiving cytarabine and idarubicin.
- The patient's respiratory distress was initially suspected to be an anaphylactic reaction, but it was later ruled out as there was no airway swelling or edema during intubation.
- The patient's temperature increased during transfusion, but the blood bank reported no transfusion reaction.
- A CT angiogram overnight ruled out pulmonary embolism (PE) although there were two small recanalized PEs and a pulmonary nodule present.
- The patient has a history of bone marrow biopsy complicated by a left gluteal hematoma without active extravasation, resulting in a 6-point hematocrit drop.
- The patient is neutropenic and on cefepime for urinary tract infection (UTI).
- The patient's echymoses extend from the left buttock to just behind the knee, likely due to the bone marrow biopsy.
- The patient received the first dose of cytarabine and idarubicin but will not be able to continue chemotherapy due to anaphylaxis.
- The patient's anemia is a combination of AML and gluteal hematoma, and they require transfusion for Hct <25, plt<50.
- The patient has transaminitis, possibly from reactivation of Hepatitis B, and will continue on lamivudine.
- The patient has type 2 diabetes mellitus (T2DM) and requires insulin sliding scale for glycemic control.
- The patient is NPO (nothing by mouth) for now and is receiving bowel regimen, protonix, and pneumoboots prophylaxis.
- The patient's disposition is ICU.

Potential Medical Complications:
1. Respiratory Distress: The patient presented with acute respiratory distress soon after receiving chemotherapy drugs cytarabine and idarubicin. This could be due to an allergic reaction, transfusion reaction, or other causes such as infection or pulmonary embolism.
2. Tachycardia: The patient had a heart rate of 160's on presentation, which could be secondary to fever, respiratory distress, and intramuscular epinephrine administration. It has since resolved.
3. Fever: The patient had a fever of 103.2 degrees on presentation. As a neutropenic patient, this could be due to infection, chemotherapy, or AML itself. Appropriate antibiotics have been initiated, and further investigations are planned.
4. Echymoses: The patient has extensive echymoses from the left buttock to just behind the knee, likely resulting from the bone marrow biopsy. This could indicate a bleeding disorder or coagulopathy.
5. Anemia: The patient's anemia is a combination of AML and gluteal hematoma. Trans"
114477.0,252858,2194-03-08 10:42:00,Physician ,Physician Attending Progress Note,"TITLE:
   Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   24 Hour Events:
 ULTRASOUND - At [**2194-3-7**] 08:00 AM
   bilat LE
 INVASIVE VENTILATION - STOP [**2194-3-7**] 12:55 PM
 Extubated yesterday
 unit pRBC for low hct
   History obtained from [**Hospital 31**] Medical records
   Patient unable to provide history: Language barrier
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Cefipime - [**2194-3-8**] 03:47 AM
   Vancomycin - [**2194-3-8**] 08:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2194-3-7**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2194-3-8**] 10:42 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 35.7
C (96.3
   HR: 66 (59 - 70) bpm
   BP: 146/81(108) {131/61(87) - 161/81(111)} mmHg
   RR: 18 (9 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 61 Inch
           Total In:
                                                                  3,741 mL
                                                                  2,358 mL
   PO:
                                                                    250 mL
                                                                    100 mL
   TF:
   IVF:
                                                                  3,183 mL
                                                                  1,908 mL
   Blood products:
                                                                    238 mL
                                                                    350 mL
   Total out:
                                                                  4,130 mL
                                                                  1,135 mL
   Urine:
                                                                  4,130 mL
                                                                  1,135 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -389 mL
                                                                  1,223 mL
   Respiratory support
   O2 Delivery Device: None
   Ventilator mode: Standby
   Vt (Spontaneous): 450 (450 - 450) mL
   PS : 5 cmH2O
   RR (Spontaneous): 20
   PEEP: 5 cmH2O
   FiO2: 40%
   SpO2: 97%
   ABG: ///21/
   Ve: 7.8 L/min
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender
   Skin:  Warm
   Neurologic: Attentive, Responds to: Not assessed, Movement: Not
   assessed, Tone: Not assessed
   Labs / Radiology
   8.8 g/dL
   90 K/uL
   179 mg/dL
   0.6 mg/dL
   21 mEq/L
   3.5 mEq/L
   15 mg/dL
   114 mEq/L
   143 mEq/L
   24.5 %
   0.3 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
                             [**2194-3-7**]  10:11 AM
                             [**2194-3-7**]  05:47 PM
                             [**2194-3-8**]  03:31 AM
   WBC
   0.7
   0.4
   0.3
   Hct
   25.6
   23.8
   27.2
   26.2
   26.6
   24.5
   Plt
   108
   104
   109
   105
   90
   Cr
   0.6
   0.5
   0.6
   TCO2
   24
   24
   Glucose
   [**Telephone/Fax (3) 4280**]
   Other labs: PT / PTT / INR:14.8/32.3/1.3, CK / CKMB / Troponin-T:440//,
   ALT / AST:49/49, Alk Phos / T Bili:114/0.5, Differential-Neuts:50.0 %,
   Band:0.0 %, Lymph:38.0 %, Mono:0.0 %, Eos:0.0 %, Lactic Acid:1.8
   mmol/L, Albumin:3.0 g/dL, LDH:1123 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:3.2 mg/dL
   Assessment and Plan
   Assessment and Plan
   78 yo Cantonese-speaking male admitted last week with AML s/p first
   cycle of idarubucin/cytarabine with [**Hospital 4257**] transferred to [**Hospital Unit Name 10**] with
   acute resp distress requiring intubation and concerns for anaphylaxis
   or transfusion reaction.
   #Respiratory Distress:
   - now resolved
   - extubated, doing well
   - etiology remains unclear
   - Off IV decadron today
    #Tachycardia:
   -resolved
   #Neutropenic fever:
   - afebrile x 24hr
   - Cefepime/vanc empiric pending cx data
   - F/U cultures
   - Trend counts - still neutropenic
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation.  Vascular saw o/n
 no compartment
   syndrome.
   - F/U negative
   #AML:
   - Heme team following
   - Family concerned re: future chemo - want to discuss with heme/onc
   folks prior to restart
   - Blood products to maintain Hct of 25 / Plts of 50.
   - q8h Hct
   Other issues per resident note.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition :
   Total time spent:
","Based on the provided progress note, the patient is a 78-year-old male with a history of acute myeloid leukemia (AML) who was admitted last week after experiencing respiratory distress and potential anaphylaxis or transfusion reaction. The patient required intubation and was transferred to the ICU.

The patient's current status is as follows:
- Respiratory distress has resolved, and the patient was successfully extubated.
- Tachycardia is resolved.
- Neutropenic fever is currently not present, and the patient is on cefepime and vancomycin empiric antibiotics pending culture data. Cultures are being followed up, and trend counts show that the patient remains neutropenic.
- The patient has ecchymoses extending from the left buttock to just behind the knee. This is a complication from a recent bone marrow biopsy that also resulted in a left gluteal hematoma. Vascular access was obtained overnight, but no compartment syndrome was found. The ecchymoses are being monitored, and no active extravasation was observed.
- The patient's AML is being managed by the hematology team, and there are concerns regarding future chemotherapy. The family wants to discuss this with the oncology team before restarting treatment. Blood products are being given to maintain a hematocrit (Hct) level of 25 and platelet count (Plts) of 50.
- The patient's vital signs are stable, with a blood"
114477.0,252858,2194-03-09 07:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint: stridor, resp distress
   24 Hour Events:
   -Afternoon Hct and CK improved
   -Family in discussion with BMT attg decided to continue with 7+3 plan
   believing clinical situation not extremely consistent with anyphylaxis
   -Patient received chemotherapy w/o event
   History obtained from Patient
   Allergies:
   History obtained from PatientCytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Vancomycin - [**2194-3-8**] 08:10 PM
   Cefipime - [**2194-3-9**] 04:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2194-3-8**] 08:10 PM
   Other medications:
   Changes to medical and family history: none
   Review of systems is unchanged from admission except as noted below
   Review of systems: denies pain. Limited [**2-17**] language barrier
   Flowsheet Data as of  [**2194-3-9**] 07:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.2
C (97.2
   Tcurrent: 35.7
C (96.2
   HR: 70 (58 - 78) bpm
   BP: 158/67(99) {138/62(88) - 158/81(109)} mmHg
   RR: 17 (13 - 24) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 61 Inch
             Total In:
                                                                  6,043 mL
                                                                  1,853 mL
   PO:
                                                                  1,080 mL
                                                                    400 mL
   TF:
   IVF:
                                                                  4,613 mL
                                                                  1,453 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                  3,675 mL
                                                                  2,120 mL
   Urine:
                                                                  3,675 mL
                                                                  2,120 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,368 mL
                                                                   -267 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///20/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Crackles :
   fine crackles at bases)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis
   Skin:  Warm, No(t) Rash: , No(t) Jaundice
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Normal
   Labs / Radiology
   99 K/uL
   9.4 g/dL
   107 mg/dL
   0.5 mg/dL
   20 mEq/L
   3.3 mEq/L
   14 mg/dL
   113 mEq/L
   140 mEq/L
   26.8 %
   0.3 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
                             [**2194-3-7**]  10:11 AM
                             [**2194-3-7**]  05:47 PM
                             [**2194-3-8**]  03:31 AM
                             [**2194-3-8**]  02:30 PM
                             [**2194-3-9**]  04:47 AM
   WBC
   0.7
   0.4
   0.3
   0.4
   0.3
   Hct
   25.6
   23.8
   27.2
   26.2
   26.6
   24.5
   28.1
   26.8
   Plt
   108
   104
   109
   105
   90
   99
   99
   Cr
   0.6
   0.5
   0.6
   0.5
   TCO2
   24
   24
   Glucose
   [**Telephone/Fax (3) 4293**]07
   Other labs: PT / PTT / INR:14.8/30.9/1.3, CK / CKMB / Troponin-T:236//,
   ALT / AST:41/34, Alk Phos / T Bili:100/0.5, Differential-Neuts:62.0 %,
   Band:0.0 %, Lymph:36.0 %, Mono:0.0 %, Eos:0.0 %, Lactic Acid:1.8
   mmol/L, Albumin:3.0 g/dL, LDH:763 IU/L, Ca++:8.2 mg/dL, Mg++:2.2 mg/dL,
   PO4:3.2 mg/dL
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 2**])
 ANEMIA, OTHER
   78 yo Chinese male with new diagnosis [**Hospital 4230**] transferred to [**Hospital Unit Name 10**] in acute
   respiratory distress soon after cytarabine and idarubicin
   administration.
   #Respiratory Distress: Patient with tachypnea, stridor, and accessory
   muscle use roughly one hour after cytarabine and idarubicin
   administration.  He was suspected to have an anaphylactic reaction and
   was given solumedrol 125mg IV X1, benadryl 25mg IV X1, epinephrine .3mg
   IM X1, and inhaled racemic epinephrine without response.  Anesthesia
   did not report airway swelling or edema during intubation, making
   anaphylaxis less likely. Was thought to possibly be from transfusion
   reaction, as it was reported that his temperature increased during
   transfusion- however per blood bank, there was no transfusion rxn.  CTA
   overnight ruled out PE although there were 2 v small recanulated PE
   and a pulm nodule. S/p extubation on [**2194-3-7**] and is breathing
   comfortably but etiology of respiratory distress remains unclear.
   - Continue dexamethasone
   - oncology would like to treat with chemo today; will discuss treatment
   options with family, risks/benefits of continued treatment and
   different agents
   - will stay in ICU if receiving next dose of chemo today; otherwise,
   call out to floor
   #Febrile neutropenia:103.2 on presentation. Patient is neutropenic.  On
   cefepime for UTI. [**Month (only) 11**] be from chemotherapy vs. infection vs. AML.  Will
   cover with Vancomycin, given PICC placement.
   -Continue cefepime, vanco
   -f/u blood, sputum, urine cx.
   #Echymoses:extending from left buttock to just behind knee. History of
   bone marrow biopsy last friday, complicated by left gluteal hematoma
   without active extravasation. .Had a 6 point hematocrit drop 2/18. CT
   pelvis showed no acute change in size of hematoma on prelim read.  Hct
   stabilizing, LLE LENIs neg.
   -trend Hct, plt, CK.
   #AML - Had first dose of cytarabine and idarubicin [**3-6**].  Will not be
   able to continue given anaphylaxis. Future therapy will be per oncology
   team.
   -f/u heme onc recs
   - respiratory distress mgmnt as above
   #. Anemia - Combination of AML and gluteal hematoma.
   - transfuse for Hct <25, plt<50
   #.Transaminitis: Possibly form reactivation of Hep B, as is HepB core
   IgM positive.
   - continue lamivudine.
   -f/u with hepatology
   #. T2DM - Insulin sliding scale
   FEN
 NPO for now
   PPX: Bowel regimen, protonix,  Pneumoboots
   Dispo - ICU
   ICU Care
   Nutrition: reg diabetic diet
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:Transfer to floor
","Summary:
The patient is a 78-year-old male with a new diagnosis of acute respiratory failure, possibly due to anaphylaxis after receiving cytarabine and idarubicin. He also has anemia, febrile neutropenia, echymoses, AML, anemia, transaminitis, and type 2 diabetes mellitus. The patient is currently in the ICU and is being treated with various medications and therapies. The etiology of his respiratory distress remains unclear.

Potential Medical Complications:
1. Respiratory Failure: The patient's acute respiratory failure requires close monitoring and management. If not appropriately treated, it can lead to hypoxia and subsequent organ damage.

2. Anaphylaxis: Although the patient has been treated for anaphylaxis, there is still a risk of recurrence. Close monitoring and prompt administration of epinephrine are crucial in case of another anaphylactic reaction.

3. Febrile Neutropenia: The patient's neutropenic state increases the risk of infection. Close monitoring of vital signs and prompt initiation of appropriate antibiotics are necessary to prevent or treat any potential infections.

4. Echymoses: The patient has extensive echymoses extending from his left buttock to just behind the knee. This could be a result of a recent bone marrow biopsy complicated by a left gluteal hematoma. Monitoring for any signs of bleeding or worsening hematoma is important.

5. Acute My"
114477.0,252858,2194-03-09 11:44:00,Physician ,Physician Attending Progress Note,"TITLE:
   Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   - Chemo administered yesterday w/o adverse effect/recurrence of sx
   History obtained from Medical records
   Patient unable to provide history: Language barrier, cantonese
   Allergies:
   Cytarabine
   Anaphylaxis;
   Last dose of Antibiotics:
   Cefipime - [**2194-3-9**] 04:00 AM
   Vancomycin - [**2194-3-9**] 08:00 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2194-3-8**] 08:10 PM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2194-3-9**] 11:44 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.2
C (97.2
   Tcurrent: 35
C (95
   HR: 66 (58 - 82) bpm
   BP: 162/81(113) {140/62(88) - 162/81(113)} mmHg
   RR: 16 (13 - 23) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 61 Inch
             Total In:
                                                                  6,043 mL
                                                                  2,855 mL
   PO:
                                                                  1,080 mL
                                                                    600 mL
   TF:
   IVF:
                                                                  4,613 mL
                                                                  2,255 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                  3,675 mL
                                                                  2,640 mL
   Urine:
                                                                  3,675 mL
                                                                  2,640 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,368 mL
                                                                    215 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   General Appearance: Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Trace, Left: 1+, No(t) Cyanosis
   Skin:  Warm
   Neurologic: Attentive, Responds to: Verbal stimuli, Movement: Not
   assessed, Tone: Not assessed
   Labs / Radiology
   9.4 g/dL
   99 K/uL
   107 mg/dL
   0.5 mg/dL
   20 mEq/L
   3.3 mEq/L
   14 mg/dL
   113 mEq/L
   140 mEq/L
   26.8 %
   0.3 K/uL
        [image002.jpg]
                             [**2194-3-6**]  06:31 PM
                             [**2194-3-6**]  10:50 PM
                             [**2194-3-6**]  11:27 PM
                             [**2194-3-7**]  04:21 AM
                             [**2194-3-7**]  05:25 AM
                             [**2194-3-7**]  10:11 AM
                             [**2194-3-7**]  05:47 PM
                             [**2194-3-8**]  03:31 AM
                             [**2194-3-8**]  02:30 PM
                             [**2194-3-9**]  04:47 AM
   WBC
   0.7
   0.4
   0.3
   0.4
   0.3
   Hct
   25.6
   23.8
   27.2
   26.2
   26.6
   24.5
   28.1
   26.8
   Plt
   108
   104
   109
   105
   90
   99
   99
   Cr
   0.6
   0.5
   0.6
   0.5
   TCO2
   24
   24
   Glucose
   [**Telephone/Fax (3) 4293**]07
   Other labs: PT / PTT / INR:14.8/30.9/1.3, CK / CKMB / Troponin-T:236//,
   ALT / AST:41/34, Alk Phos / T Bili:100/0.5, Differential-Neuts:62.0 %,
   Band:0.0 %, Lymph:36.0 %, Mono:0.0 %, Eos:0.0 %, Lactic Acid:1.8
   mmol/L, Albumin:3.0 g/dL, LDH:763 IU/L, Ca++:8.2 mg/dL, Mg++:2.2 mg/dL,
   PO4:3.2 mg/dL
   Assessment and Plan
   78 yo Cantonese-speaking male admitted last week with AML s/p first
   cycle of idarubucin/cytarabine with [**Hospital 4257**] transferred to [**Hospital Unit Name 10**] with
   acute resp distress requiring intubation and concerns for anaphylaxis
   or transfusion reaction.
   #Respiratory Distress:
   - now resolved
   - extubated, doing well x 2 days
   - etiology remains unclear
   #Tachycardia:
   -resolved
   #Neutropenic fever:
   - afebrile x 48hr
   - Cefepime/vanc empiric pending cx data
   - F/U cultures
   - Trend counts - still neutropenic
   #Echymoses:
   - extending from left buttock to just behind knee. History of bone
   marrow biopsy last friday, complicated by left gluteal hematoma without
   active extravasation.
   - Vascular saw
 no compartment syndrome.
   #AML:
   - Heme team following
   - Chemo restarted yesterday w/o adverse effect
   - Blood products to maintain Hct of 25 / Plts of 50.
   - q8h [**Hospital 4297**]
   Transfer to floor
   Other issues per resident note.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2194-3-6**] 05:51 PM
   PICC Line - [**2194-3-6**] 06:27 PM
   Arterial Line - [**2194-3-6**] 10:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition :
   Total time spent:
","Based on the provided progress note, the patient is a 78-year-old male with a history of acute myeloid leukemia (AML) who was admitted to the ICU for acute respiratory distress and concerns of anaphylaxis or transfusion reaction. The patient required intubation but is now extubated and doing well for two days. The etiology of the respiratory distress remains unclear.

The patient also had tachycardia, which has resolved, and neutropenic fever that is currently afebrile for 48 hours. The patient is still neutropenic, and cultures are pending. Empiric antibiotics (cefepime and vancomycin) have been started, and the patient's blood counts are being monitored.

Additionally, the patient has multiple echymoses extending from the left buttock to just behind the knee. This is believed to be related to a recent bone marrow biopsy that resulted in a left gluteal hematoma without active extravasation. There is no compartment syndrome, and the patient is receiving blood products to maintain a hematocrit (Hct) of 25 and platelets (Plts) of 50.

The patient's AML is being managed by the heme team, and chemotherapy was restarted yesterday without any adverse effects. The patient's condition appears to be stable at this time."
